Circulating Tumor Material in Colorectal Cancer and Melanoma

Abramson Cancer Center at Penn Medicine

Status: Completed

Conditions: Colorectal Cancer and Melanoma

Treatments: Other: blood collection

Study type: Observational

Funder types: Other

Identifiers

NCT02907086

UPCC 12916

Details and patient eligibility

About

Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma

Enrollment: 7 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The subject must be a patient at the Hospital of the University of Pennsylvania

  1. Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania
  2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania.

• The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf.

• The subject must be 18 years of age or older.

Exclusion criteria

• The subject is not able to provide informed consent.

Trial design

7 participants in 2 patient groups

colorectal cancer

Treatment:

Other: blood collection

melanoma

Treatment:

Other: blood collection